Project Description: A Phase 1, Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of an Oxfendazole Tablet Formulation in a Randomized, Double-Blind, Placebo-Controlled Design after Single and Multiple Oral Dosing in Healthy Adult Volunteers A Phase 1, Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of an Oxfendazole Tablet Formulation in a Randomized, Double-Blind, Placebo-Controlled Design after Single and Multiple Oral Dosing in Healthy Adult Volunteers
Principal Investigator : Alwisa Urassa
Department Name :
Time frame: (2022-01-01) - (2022-09-30)